Ina Research Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
2,778
2,995
2,117
2,296
2,426
Cost of Goods Sold (COGS) incl. D&A
2,142
2,383
1,754
1,713
1,715
Gross Income
637
612
362
583
711
SG&A Expense
570
564
570
526
514
EBIT
66
47
208
56
196
Unusual Expense
-
-
940
-
-
Non Operating Income/Expense
11
14
3
12
17
Interest Expense
28
30
36
40
40
Pretax Income
49
32
1,181
28
173
Income Tax
34
24
62
7
24
Consolidated Net Income
15
8
1,243
21
149
Net Income
70
8
1,204
32
142
Net Income After Extraordinaries
70
8
1,204
32
142
Net Income Available to Common
70
8
1,204
32
142
EPS (Basic)
23.49
2.76
401.60
10.63
47.29
Basic Shares Outstanding
3
3
3
3
3
EPS (Diluted)
23.49
2.76
401.60
10.63
47.29
Diluted Shares Outstanding
3
3
3
3
3
EBITDA
281
255
26
179
299
Non-Operating Interest Income
-
-
-
-
-
Minority Interest Expense
55
-
39
11
7

About Ina Research

View Profile
Address
2148-188 Nishiminowa
Ina 399
Japan
Employees -
Website http://www.ina-research.co.jp
Updated 09/14/2018
Ina Research, Inc. engages in the development of pharmaceutical products. The company operates through Entrusted Testing and Environment segment. The Entrusted Testing segment covers the safe testing of pharmaceuticals, medical equipment, pesticides, food, and other chemicals and also handles the commissioned clinical trials for drug development.